Biomics Biopharma (ASX:BBM) Operating Cash Flow per Share : A$ (TTM As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Operating Cash Flow per Share?

Biomics Biopharma's operating cash flow per share for the six months ended in . 20 was A$0.00. Biomics Biopharma does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Biomics Biopharma's Operating Cash Flow per Share or its related term are showing as below:

ASX:BBM's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.35
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Biomics Biopharma Operating Cash Flow per Share Historical Data

The historical data trend for Biomics Biopharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Operating Cash Flow per Share Chart

Biomics Biopharma Annual Data

Trend

Operating Cash Flow per Share

Biomics Biopharma Semi-Annual Data

Operating Cash Flow per Share

Competitive Comparison of Biomics Biopharma's Operating Cash Flow per Share

For the Biotechnology subindustry, Biomics Biopharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomics Biopharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's Price-to-Operating-Cash-Flow falls into.

Biomics Biopharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Biomics Biopharma's Operating Cash Flow per Share for the fiscal year that ended in . 20 is calculated as

Operating Cash Flow per Share (A: . 20 )	=	Cash Flow from Operations (A: . 20 )	/	Shares Outstanding (Diluted Average) (A: . 20 )
	=		/	0
	=

Biomics Biopharma's Operating Cash Flow per Share for the quarter that ended in . 20 is calculated as

Operating Cash Flow per Share (Q: . 20 )	=	Cash Flow from Operations (Q: . 20 )	/	Shares Outstanding (Diluted Average) (Q: . 20 )
	=		/	0
	=

Biomics Biopharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Operating Cash Flow per Share

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines